|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 274.51 USD | -0.22% |
|
+0.28% | -0.08% |
| 19/03 | The Cigna Group Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 01:50 PM | |
| 13/03 | Quest Diagnostics Incorporated Appoints Timothy Wentworth as Director | CI |
Company Valuation: Cigna
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 76,106 | 1,01,304 | 87,625 | 76,809 | 73,521 | 72,538 | - | - |
| Change | - | 33.11% | -13.5% | -12.34% | -4.28% | -1.34% | - | - |
| Enterprise Value (EV) 1 | 1,04,695 | 1,26,473 | 1,10,733 | 1,01,231 | 97,308 | 92,830 | 88,484 | 83,952 |
| Change | - | 20.8% | -12.45% | -8.58% | -3.88% | -4.6% | -4.68% | -5.12% |
| P/E ratio | 14.6x | 15.6x | 17.2x | 22.8x | 12.4x | 11.3x | 9.89x | 8.97x |
| PBR | 1.57x | 2.21x | 1.89x | 1.84x | 1.74x | 1.62x | 1.5x | 1.23x |
| PEG | - | 0.4x | -0.9x | -0.8x | 0.1x | 1.19x | 0.7x | 0.9x |
| Capitalization / Revenue | 0.44x | 0.56x | 0.45x | 0.31x | 0.27x | 0.26x | 0.24x | 0.23x |
| EV / Revenue | 0.6x | 0.7x | 0.57x | 0.41x | 0.35x | 0.33x | 0.3x | 0.27x |
| EV / EBITDA | 9.42x | 11x | 9.24x | 8.38x | 7.88x | 7.11x | 6.22x | 5.64x |
| EV / EBIT | 13.2x | 15x | 13x | 10.7x | 10.6x | 9.61x | 8.58x | 7.65x |
| EV / FCF | 17.3x | 17.2x | 10.8x | 11.3x | - | 10.2x | 8.7x | 7.86x |
| FCF Yield | 5.77% | 5.82% | 9.25% | 8.85% | - | 9.84% | 11.5% | 12.7% |
| Dividend per Share 2 | 4 | 4.48 | 4.92 | 5.6 | - | 6.215 | 6.488 | 6.775 |
| Rate of return | 1.74% | 1.35% | 1.64% | 2.03% | - | 2.26% | 2.36% | 2.46% |
| EPS 2 | 15.73 | 21.3 | 17.39 | 12.12 | 22.18 | 24.29 | 27.83 | 30.66 |
| Distribution rate | 25.4% | 21% | 28.3% | 46.2% | - | 25.6% | 23.3% | 22.1% |
| Net sales 1 | 1,74,078 | 1,80,642 | 1,95,322 | 2,47,099 | 2,74,900 | 2,82,998 | 2,98,938 | 3,15,448 |
| EBITDA 1 | 11,118 | 11,522 | 11,980 | 12,083 | 12,351 | 13,053 | 14,230 | 14,894 |
| EBIT 1 | 7,935 | 8,414 | 8,536 | 9,417 | 9,200 | 9,661 | 10,314 | 10,980 |
| Net income 1 | 5,365 | 6,668 | 5,164 | 3,434 | 5,957 | 6,465 | 7,481 | 7,784 |
| Net Debt 1 | 28,589 | 25,169 | 23,108 | 24,422 | 23,787 | 20,292 | 15,945 | 11,413 |
| Reference price 2 | 229.63 | 331.34 | 299.45 | 276.14 | 275.23 | 275.12 | 275.12 | 275.12 |
| Nbr of stocks (in thousands) | 3,31,428 | 3,05,739 | 2,92,620 | 2,78,153 | 2,67,126 | 2,63,661 | - | - |
| Announcement Date | 03/02/22 | 03/02/23 | 02/02/24 | 30/01/25 | 05/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 11.34x | 0.33x | 7.11x | 2.26% | 7.25TCr | ||
| 18.64x | 0.75x | 11.89x | 2.81% | 28TCr | ||
| 13.19x | 0.47x | 9.13x | 2.24% | 6.94TCr | ||
| 22.42x | 0.21x | 12.6x | 1.97% | 2.38TCr | ||
| 19.4x | 0.09x | 9.13x | -.--% | 1.84TCr | ||
| 45.97x | 0.16x | 10.53x | -.--% | 781.26Cr | ||
| 160.02x | 0.76x | 26.02x | -.--% | 428.61Cr | ||
| 14.53x | 0.84x | 5x | -.--% | 133Cr | ||
| -283.52x | 0.32x | 16.34x | -.--% | 106.51Cr | ||
| 47.33x | 2.65x | 14x | 0.59% | 28Cr | ||
| Average | 6.93x | 0.66x | 12.17x | 0.99% | 4.83TCr | |
| Weighted average by Cap. | 18.01x | 0.58x | 10.80x | 2.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- CI Stock
- Valuation Cigna
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















